PS
LKFT

Planned Solutions’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Planned Solutions’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$2.88K – 310
2024
Q3 		$2.88K Buy
+100
New +$2.72K ﹤0.01% 529
2024
Q1 		– Sell
-100
Closed -$4.07K – 263
2023
Q4 		$4.07K Buy
+100
New +$3.68K ﹤0.01% 477

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Planned Solutions's LKFT Position: Q4 2024 in Review

Planned Solutions sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2024, closing a stake of 100 shares — an estimated $2.88K sold.

Planned Solutions first reported a position in LKFT in Q4 2023 and held it in 2 quarters. The position peaked at $4.07K in Q4 2023. 81 funds tracked by Wall St. Rank hold LKFT as of Q4 2024.

  • Planned Solutions reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Planned Solutions sold 100 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2024, an estimated $2.88K.
  • Planned Solutions first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2023 and held it in 2 quarters.
  • Planned Solutions's Lakefront Biotherapeutics American Depositary Shares position peaked at $4.07K in Q4 2023.
  • 81 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2024.

Based on Planned Solutions's 13F filing for Q4 2024, filed 17 Jan 2025.